Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia

Blood

Volumn 117, Issue 8, 2011, Pages 2340-2347

  Kawedia, Jitesh D ^a   Kaste, Sue C ^a   Pei, Deqing ^a   Panetta, John C ^a   Cai, Xiangjun ^a   Cheng, Cheng ^a   Neale, Geoffrey ^a   Howard, Scott C ^a   Evans, William E ^a   Pui, Ching Hon ^a   Relling, Mary V ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE; ACID PHOSPHATASE 1; ALBUMIN; ASPARAGINASE; DEXAMETHASONE; HYDROCORTISONE; LIPID; PREDNISONE; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BODY MASS; BONE NECROSIS; CELL DIFFERENTIATION; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG CLEARANCE; FEMALE; GROUPS BY AGE; HUMAN; HYDROCORTISONE BLOOD LEVEL; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOBLAST; PHARMACOGENETICS; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 79952143869     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-10-311969     Document Type: Article

References (41)

1. Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med. 2006;354(2):166-178. (Pubitemid 43076714)
2. Pui CH, Campana D, Pei D, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 2009;360(26): 2730-2741.
3. Gaynon PS, Carrel AL. Glucocorticosteroid therapy in childhood acute lymphoblastic leukemia. Adv Exp Med Biol. 1999;457:593-605. (Pubitemid 129735357)
4. Silverman LB, Gelber RD, Dalton VK, et al. Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. Blood. 2001;97(5):1211-1218. (Pubitemid 32183741)
5. Relling MV, Yang W, Das S, et al. Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia. J Clin Oncol. 2004;22(19):3930-3936. (Pubitemid 41079875)
6. Niinimaki RA, Harila-Saari AH, Jartti AE, et al. High body mass index increases the risk for osteonecrosis in children with acute lymphoblastic leukemia. J Clin Oncol. 2007;25(12):1498-1504. (Pubitemid 46733076)
7. Sala A, Mattano LA Jr, Barr RD. Osteonecrosis in children and adolescents with cancer: an adverse effect of systemic therapy. Eur J Cancer. 2007; 43(4):683-689. (Pubitemid 46502899)
8. Patel B, Richards SM, Rowe JM, Goldstone AH, Fielding AK. High incidence of avascular necrosis in adolescents with acute lymphoblastic leukaemia: a UKALL XII analysis. Leukemia. 2008;22(2):308-312. (Pubitemid 351250536)
9. Bostrom BC, Sensel MR, Sather HN, et al. Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood. 2003;101(10):3809-3817. (Pubitemid 36857851)
10. Burger B, Beier R, Zimmermann M, Beck JD, Reiter A, Schrappe M. Osteonecrosis: a treatment related toxicity in childhood acute lymphoblastic leukemia (ALL). Experiences from trial ALL-BFM 95. Pediatr Blood Cancer. 2005;44(3): 220-225. (Pubitemid 40209430)
11. Mattano LAJr, Sather HN, Trigg ME, Nachman JB. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group. J Clin Oncol. 2000;18(18): 3262-3272.
12. Karimova EJ, Rai SN, Howard SC, et al. Femoral head osteonecrosis in pediatric and young adult patients with leukemia or lymphoma. J Clin Oncol. 2007;25(12):1525-1531. (Pubitemid 46733079)
13. Smith RW, Margulis RR, Brennan MJ, Monto RW. The influence of ACTH and cortisone on certain factors of blood coagulation. Science. 1950; 112(2907):295-297.
14. Yamamoto T, Hirano K, Tsutsui H, Sugioka Y, Sueishi K. Corticosteroid enhances the experimental induction of osteonecrosis in rabbits with Shwartzman reaction. Clin Orthop. 1995;316: 235-243.
15. Glueck CJ, Freiberg RA, Fontaine RN, Tracy T, Wang P. Hypofibrinolysis, thrombophilia, osteonecrosis. Clin Orthop. 2001;386:19-33. (Pubitemid 32391273)
16. Yamamoto T, Irisa T, Sugioka Y, Sueishi K. Effects of pulse methylprednisolone on bone and marrow tissues: corticosteroid-induced osteonecrosis in rabbits. Arthritis Rheum. 1997;40(11):2055-2064. (Pubitemid 27494667)
17. Yun SI, Yoon HY, Jeong SY, Chung YS. Glucocorticoid induces apoptosis of osteoblast cells through the activation of glycogen synthase kinase 3beta. J Bone Miner Metab. 2009;27(2): 140-148.
18. Ribeiro RC, Fletcher BD, Kennedy W, et al. Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma. Leukemia. 2001;15(6):891-897. (Pubitemid 32529887)
19. te Winkel ML, Appel IM, Pieters R, van den Heuvel-Eibrink MM. Impaired dexamethasone-related increase of anticoagulants is associated with the development of osteonecrosis in childhood acute lymphoblastic leukemia. Haematologica. 2008; 93(10):1570-1574.
20. Aguiar De Aragao P, Lemos RB, Aquino MZ, Souza Marques HH. Hyperlipidaemia a risk factor for femoral head osteonecrosis (Legg-Calv-Perthes-like disease) in children with AIDS: case report. Braz J Infect Dis. 2002;6(3):142-145.
21. French D, Hamilton LH, Mattano LA Jr, et al. A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood. 2008;111(9):4496-4499.
22. Asano T, Takahashi KA, Fujioka M, et al. Genetic analysis of steroid-induced osteonecrosis of the femoral head. J Orthop Sci. 2003;8(3):329-333. (Pubitemid 36702081)
23. Hadjigeorgiou G, Dardiotis E, Dardioti M, Karantanas A, Dimitroulias A, Malizos K. Genetic association studies in osteonecrosis of the femoral head: mini review of the literature. Skeletal Radiol. 2008;37(1):1-7. (Pubitemid 350160505)
24. Yang L, Boyd K, Kaste SC, Kamdem Kamdem L, Rahija RJ, Relling MV. A mouse model for glucocorticoid-induced osteonecrosis: effect of a steroid holiday. J Orthop Res. 2009;27(2):169-175.
25. Yang L, Panetta JC, Cai X, et al. Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia. J Clin Oncol. 2008;26(12):1932-1939.
26. Yang JJ, Cheng C, Yang W, et al. Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia. JAMA. 2009;301(4):393-403.
27. Trevino LR, Shimasaki N, Yang W, et al. Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects. J Clin Oncol. 2009;27(35):5972-5978.
28. Shen R, Fan JB, Campbell D, et al. High-throughput SNP genotyping on universal bead arrays. Mutat Res. 2005;573(1):70-82. (Pubitemid 40514402)
29. Pritchard JK, Stephens M, Donnelly P. Inference of population structure using multilocus genotype data. Genetics. 2000;155(2):945-959. (Pubitemid 30397141)
30. Chen SC, Pei D, Yang W, et al. Genetic variations in GRIA1 on choromosone 5q33 related to asparaginase hypersensitivity. Clin Pharmacol Ther. 2010;88(2):191-196.
31. Cheng C, Pounds SB, Boyett JM, Pei D, Kuo ML, Roussel MF. Statistical significance threshold criteria for analysis of microarray gene expression data. Stat Appl Genet Mol Biol. 2004;3:Article36.
32. Haajanen J, Saarinen O, Laasonen L, Kuhlback B, Edgren J, Slatis P. Steroid treatment and aseptic necrosis of the femoral head in renal transplant recipients. Transplant Proc. 1984;16(5):1316-1319. (Pubitemid 14023591)
33. Ruderman RJ, Poehling GG, Gray R, Nardone M, Goodman W, Seigler HF. Orthopedic complications of renal transplantation in children. Transplant Proc. 1979;11(1):104-106. (Pubitemid 9171757)
34. Steinherz PG. Transient, severe hyperlipidemia in patients with acute lymphoblastic leukemia treated with prednisone and asparaginase. Cancer. 1994;74(12):3234-3239. (Pubitemid 24375082)
35. Parsons SK, Skapek SX, Neufeld EJ, et al. Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia. Blood. 1997;89(6):1886-1895. (Pubitemid 27132102)
36. Sarna S, Hoppu K, Neuvonen PJ, Laine J, Holmberg C. Methylprednisolone exposure, rather than dose, predicts adrenal suppression and growth inhibition in children with liver and renal transplants. J Clin Endocrinol Metab. 1997; 82(1):75-77. (Pubitemid 27021273)
37. Styczynski J, Pieters R, Huismans DR, Schuurhuis GJ, Wysocki M, Veerman AJ. In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia. Br J Haematol. 2000;110(4):813-818.
38. Bottini N, MacMurray J, PetersW, Rostamkhani M, Comings DE. Association of the acid phosphatase (ACP1) gene with triglyceride levels in obese women. Mol Genet Metab. 2002;77(3):226-229. (Pubitemid 35333827)
39. Zambuzzi WF, Granjeiro JM, Parikh K, Yuvaraj S, Peppelenbosch MP, Ferreira CV. Modulation of Src activity by low molecular weight protein tyrosine phosphatase during osteoblast differentiation. Cell Physiol Biochem. 2008;22(5):497-506.
40. Murphy A, Tantisira KG, Soto-Quiros ME, et al. PRKCA: a positional candidate gene for body mass index and asthma. Am J Hum Genet. 2009; 85(1):87-96.
41. Wessel J, Moratorio G, Rao F, et al. C-reactive protein, an 'intermediate phenotype' for inflammation: human twin studies reveal heritability, association with blood pressure and the metabolic syndrome, and the influence of common polymorphism at catecholaminergic/beta-adrenergic pathway loci. J Hypertens. 2007;25(2):329-343. (Pubitemid 46071931)